TickerFacts.

Company research / XNCR

Xencor Inc (XNCR)

Build a valuation ↗↓ Download CSV

CIK 0001326732 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Xencor Inc reported revenue of $125.58M. Revenue grew 13.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $104.97M.

Key ratios (year ended 2025-12-31)

-141.4%
Operating margin
-73.2%
Net margin
-14.5%
Return on year-end equity
13.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-08-05

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$104.97M$125.58M$110.49M$174.62M$164.58M$275.11M$122.69M$156.70M$40.60M$46.15M$109.02M
R&D Expense$255.76M$239.43M$227.69M$253.60M$199.56M$192.51M$169.80M$118.59M$97.50M$71.77M$51.87M
Operating Income-$216.08M-$177.50M-$178.41M-$132.36M-$82.47M$43.77M-$76.80M$13.82M-$79.37M-$43.12M$44.04M
Depreciation & Amortization$10.17M$10.51M$12.11M$11.50M$8.80M$7.49M$5.79M$4.30M$3.25M$2.03M$1.47M
EBITDA-$205.90M-$166.99M-$166.30M-$120.86M-$73.67M$51.26M-$71.00M$18.12M-$76.12M-$41.09M$45.51M
Net Income-$163.32M-$91.92M-$232.62M-$133.13M-$55.18M$82.63M-$69.33M$26.88M-$70.41M-$38.49M$45.12M
EPS (Diluted)n/a-$1.24-$3.58-$2.20-$0.93$1.37-$1.21$0.46-$1.31-$0.82$1.07
Total Assets$724.96M$875.50M$951.95M$965.13M$846.27M$838.21M$703.24M$670.25M$576.73M$390.20M$428.56M
Total Liabilities$221.73M$239.91M$277.92M$303.05M$118.77M$104.71M$130.80M$77.05M$55.05M$73.74M$114.61M
Shareholders' Equity$503.23M$635.59M$677.61M$661.75M$727.50M$733.50M$572.44M$593.20M$521.68M$316.46M$337.93M
Cash & Equivalents$44.66M$54.07M$40.88M$53.79M$53.94M$143.48M$163.54M$50.31M$26.25M$16.53M$14.53M
Operating Cash Flow-$205.81M-$135.12M-$202.19M-$77.93M$24.48M-$16.85M-$5.00M$64.37M-$79.76M-$33.60M$95.24M
Capital Expenditures$2.47M$3.15M$6.10M$18.45M$38.49M$13.30M$10.54M$7.35M$7.21M$5.31M$1.51M
Free Cash Flow-$208.28M-$138.27M-$208.28M-$96.37M-$14.01M-$30.15M-$15.54M$57.02M-$86.97M-$38.91M$93.73M
Shares Outstanding74.33M71.87M70.26M61.00M60.00M59.36M57.87M56.90M56.28M47.00M46.57M
Weighted Average Diluted Sharesn/a74.24M65.04M60.50M59.65M60.50M57.21M58.47M53.94M46.82M42.39M
EPS (Basic)n/a-$1.24-$3.58-$2.20-$0.93$1.42-$1.21$0.48-$1.31-$0.82$1.09

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView